Koselugo (selumetinib)

pCPA File Number: 22375

Negotiation Status:

Active Negotiation

Indication(s):

For the treatment of pediatric patients aged 2 years and above, with neurofibromatosis type 1 who have symptomatic, inoperable plexiform neurofibromas

Sponsor/Manufacturer:

Alexion Pharma GMBH

CADTH Project Number:

SR0764

pCPA Engagement Letter Issued:

2024-03-12

Negotiation Process Concluded:

Not Applicable